Core Viewpoint - The report from Tianfeng Securities indicates that Milkyway's main business prices are either at historical lows or experiencing minimal year-on-year fluctuations, which negatively impacts profit growth [1] Price Trends and Profitability - Shipping rates in global freight have seen significant declines, while prices for chemicals and domestic chemical shipping rates remain low [1] - Future price recovery is anticipated due to economic recovery, stabilization in the chemical industry, and reduced competition, which could accelerate profit growth for Milkyway [1] - Even with a price decline in the first half of 2025, Milkyway's net profit attributable to shareholders is expected to grow by 13%, demonstrating strong growth resilience [1] Potential for Profit Growth - If the year-on-year price decline narrows or turns into an increase, Milkyway's net profit could see accelerated growth, leading to a potential rise in valuation [1] - Price increases could also reduce business risks and lower asset and credit impairment losses, further driving up valuation [1] Market Sentiment and Valuation - As market risk appetite increases, the risk premium for trade businesses is expected to narrow, which may lead to a rise in Milkyway's valuation [1] - The expectation of price stabilization and continued growth in business volume could gradually release profits [1] - A target price-to-earnings ratio of 16 times is set, corresponding to a target price of 81.49 yuan, with an initial "buy" rating assigned [1]

Group 1: Macro Strategy and Market Overview - The report emphasizes the importance of coordinated fiscal and monetary policies to support economic recovery amid a complex market environment [3] - In the equity market, major indices experienced slight adjustments, with the ChiNext Index rising by 2.35% in the first week of September [3] - The central bank maintained a loose liquidity environment, with the DR007 rate staying below 1.5% [3] Group 2: Pharmaceutical Industry Insights - The weight loss market is rapidly growing, with over 2.6 billion people affected by overweight/obesity globally as of 2020, projected to exceed 4 billion by 2035 [5] - Novo Nordisk's oral version of semaglutide has been accepted for FDA review, marking a significant advancement in the oral GLP-1 weight loss drug market [5] - Data underperformance in oral GLP-1 pipelines may accelerate domestic BD opportunities, with potential for local drug companies to achieve significant results [5] Group 3: Energy Sector Analysis - U.S. shale oil companies have reduced capital expenditure and production guidance for 2025, indicating a cautious outlook [6][8] - The report predicts that if WTI prices remain below $60 per barrel, shale oil production may decline significantly [8] - OPEC+ is expected to increase production, potentially leading to oversupply and price corrections in the fourth quarter [9] Group 4: Chemical Industry Developments - China has become the world's largest new energy storage market, with installed capacity reaching 73.76 million kilowatts by the end of 2024 [11] - Prices for paraquat have risen due to strong demand and tight supply, while epoxy chloropropane market transactions have increased [11] Group 5: Retail Sector Performance - Chongqing Department Store reported a revenue of 8 billion yuan in H1 2025, a 10% year-on-year decline, but net profit increased by 8.7% [12] - The company has successfully adjusted 32 stores, resulting in a 53% increase in customer traffic [12] Group 6: Company-Specific Insights - Milky Way's net profit is expected to grow from 6.6 billion to 9.3 billion yuan from 2025 to 2027, with a target price of 81.49 yuan based on a PE of 16 [42][43] - China Ruyi's revenue for H1 2025 reached 2.206 billion yuan, a 19.93% increase, with a net profit turnaround to 1.228 billion yuan [36][37]

Investment Rating - The report assigns a "Buy" rating for the company, with a target price of 81.49 CNY based on a target PE of 16 times [6]. Core Insights - The company's main business prices are at historical lows, which has negatively impacted profit growth. However, prices are expected to recover with economic recovery and stabilization in the chemical industry, potentially accelerating profit growth [1][49]. - The company is actively expanding its business volume through product diversification, regional expansion, and market share increase, leading to sustained growth in freight forwarding, chemical sales, shipping, and warehousing [2]. - Profitability is expected to increase, and valuation may rise as profit growth accelerates and risk preferences improve among investors [3]. Summary by Sections 1. Company Overview - The company is a leading provider of integrated supply chain services in China, focusing on freight forwarding, warehousing, and transportation, with a strong emphasis on chemical distribution [15][29]. 2. Price Recovery Potential - Current prices related to the company's main business are at historical lows, affecting profit growth. Future price recovery is anticipated due to economic recovery and stabilization in the chemical sector [1][49]. 3. Business Growth Strategies - The company is expanding its product categories, regions, and market share, with significant growth expected in freight forwarding and chemical distribution [2][41]. 4. Profitability and Valuation - The company is projected to achieve net profits of 660.95 million CNY, 805.34 million CNY, and 932.98 million CNY for the years 2025, 2026, and 2027 respectively, indicating strong profit growth [4][5]. - The company's valuation is expected to rise as profit growth accelerates and market risk preferences improve [3][44]. 5. Financial Data - The company’s revenue is projected to grow from 9,752.55 million CNY in 2023 to 16,738.82 million CNY in 2027, with a CAGR of 39% from 2015 to 2024 [5][44].

Core Viewpoint - Milkyway, a leading professional intelligent supply chain service provider in China, has secured a significant contract worth approximately 180 million yuan with China National Offshore Oil Corporation (CNOOC) for logistics services, marking a recognition of its delivery capabilities in the chemical supply chain sector [2][3]. Financial Performance - In the first half of 2025, Milkyway achieved a revenue of 7.035 billion yuan, representing a year-on-year growth of 17.40%. The net profit attributable to shareholders was 352 million yuan, up 13.12% from the previous year [5][6]. - The company's cash flow from operating activities reached 1.245 billion yuan, showing a substantial increase of 636.00% year-on-year, providing a strong foundation for business expansion [6]. Business Development - Milkyway has established long-term partnerships with numerous renowned companies in the chemical, new energy, and semiconductor sectors, including BASF, Dow, and ExxonMobil, with over 10,000 effective clients [4][5]. - The company has been actively expanding its service offerings, including freight forwarding, warehousing, and transportation, while also extending into chemical distribution and new energy sectors [4]. Strategic Initiatives - Milkyway is focusing on enhancing its market competitiveness through the establishment of six major operational zones in Greater China and has initiated a global expansion strategy with subsidiaries in various countries [7][8]. - The company has significantly increased its R&D investment, with expenses rising from 6.03 million yuan in 2017 to 30.88 million yuan in the first half of 2025, reflecting a 9.1-fold increase over seven years [8][9]. Technological Advancements - As of the mid-2025 report, Milkyway has obtained a total of 116 patent certificates, including 12 invention patents and 104 utility model patents, along with 231 software copyright certificates [9].

Core Viewpoint - The announcement details the interest payment schedule for the convertible bonds issued by Milkway Intelligent Supply Chain Service Group Co., Ltd., indicating that the third interest payment will occur on September 16, 2025, for the period from September 16, 2024, to September 15, 2025 [2][12]. Group 1: Bond Details - The bond is named "2022 Milkway Chemical Supply Chain Service Co., Ltd. Publicly Issued Convertible Bonds" [5]. - The total issuance amount of the convertible bonds is RMB 872.388 million [5]. - The bond has a term of 5 years, from September 16, 2022, to September 15, 2027 [5]. - The interest rates for the bond are structured as follows: 0.3% for the first year, 0.5% for the second year, 1.0% for the third year, 1.5% for the fourth year, and 2.0% for the fifth year [5]. Group 2: Interest Payment Information - The interest payment date is set for September 16, 2025, with the interest amount being RMB 1.00 per bond (including tax) [4][12]. - The bondholders must be registered with China Securities Depository and Clearing Corporation Limited Shanghai Branch by the close of trading on September 15, 2025, to receive the interest [17]. - The interest income is subject to a personal income tax rate of 20%, resulting in a net payment of RMB 0.80 per bond after tax [19]. Group 3: Conversion and Rating - The initial conversion price for the bonds is RMB 134.55 per share, with the latest conversion price adjusted to RMB 55.72 per share [9]. - The bonds are rated AA- by China United Credit Rating Co., Ltd., with a stable outlook [10].

Summary of the Conference Call for Milky Way (密尔克卫) Industry Overview - The chemical logistics market is large but fragmented, with a high entry barrier. The national market size is expected to reach approximately 12.44 trillion yuan in 2024, with the top 100 companies accounting for only 3.6% of the market, indicating low industry concentration and high barriers to entry, which provides leading companies like Milky Way with the potential to consolidate the market [2][6][3]. Core Insights and Arguments - The chemical industry entered a downturn in the second half of 2022, but positive signals have emerged on the supply side, including continuous negative growth in capital expenditure by listed companies, exit of overseas capacity, and domestic policy adjustments, which may catalyze growth in Milky Way's core integrated warehousing and distribution business [2][3][7]. - Milky Way has adjusted its business and customer structure to cope with the industry downturn, with non-chemical customers now accounting for 40% of its business, enhancing its risk resistance and optimizing its profit model [2][3][11]. - The company's own hazardous materials warehouse area has significantly increased from approximately 120,000-130,000 square meters in 2021 to over 300,000 square meters by 2024, with self-owned warehouses accounting for nearly half, employing a volume-based pricing strategy to counteract market price declines [2][11]. - Milky Way's projected profits for 2025 and 2026 are expected to be 640 million yuan and 740 million yuan, respectively, with earnings per share (EPS) of 4.06 yuan and 4.66 yuan, reflecting year-on-year growth rates of 13.7% and 14.5%, primarily driven by growth in integrated warehousing and distribution and freight forwarding businesses [2][12]. Additional Important Insights - The company aims to reduce its debt-to-equity ratio after the peak of capital expenditure, planning to handle convertible bond projects through redemption or conversion and considering asset securitization to realize part of its assets and accelerate capital turnover [4][14]. - The distribution business is performing strongly, with expected revenue and gross profit increases of 30% and 38% in 2025, driven by the expansion into non-bulk categories such as fast-moving consumer goods, wind power resins, and compounded materials, with a projected revenue growth of 15% and gross profit growth of 17.5% in 2026 [4][18]. - Milky Way's market position is strengthened by the high entry barriers and the fragmented competitive landscape, with many competitors being regional small enterprises or large state-owned enterprises unwilling to expand [6][8]. - The chemical price index is currently at around the 20th percentile since 2012, indicating a cyclical low, with several positive supply-side signals, including a continuous decline in capital expenditure by petrochemical companies and significant overseas capacity exits [9][10]. - The company is exploring innovative business models to reduce reliance on heavy asset investments, such as management output projects in Hubei, and diversifying its customer base to include non-traditional sectors like new energy and smart manufacturing [15]. Future Outlook - Milky Way is well-positioned for future growth due to the increasing trend of consolidation among leading companies and positive changes on the supply side. The company has demonstrated strong operational capabilities and robust development strategies, laying a solid foundation for future growth [8]. - The company employs a relative valuation method for target price estimation, referencing its average price-to-earnings (PE) ratio of approximately 25 times over the past five years and comparing it with three comparable companies, projecting an average PE of 23 times for 2025 and 17 times for 2026 [19][20].

| 证券代码：603713 | 证券简称：密尔克卫 | 公告编号：2025-082 | | --- | --- | --- | | 转债代码：113658 | 转债简称：密卫转债 | | 密尔克卫智能供应链服务集团股份有限公司 关于"密卫转债"2025 年付息公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 密尔克卫智能供应链服务集团股份有限公司（更名前为"密尔克卫化工供应 链服务股份有限公司"，以下简称"发行人"或者"本公司"或者"公司"）发行 的 2022 年密尔克卫化工供应链服务股份有限公司公开发行可转换公司债券（以 下简称"密卫转债"或"可转债"），将于 2025 年 9 月 16 日开始支付自 2024 年 9 月 16 日至 2025 年 9 月 15 日期间的利息。根据《密尔克卫化工供应链服务 股份有限公司公开发行可转换公司债券募集说明书》（以下简称"《募集说明 书》"）有关条款的规定，现将有关事宜公告如下： 一、本期债券的基本情况 1、债券名称：2022 年密尔克卫化工供应链服务股份有限公司 ...

资料显示，密尔克卫智能供应链服务集团股份有限公司位于上海市浦东新区金葵路158号云璟生态社区 F1栋，成立日期1997年3月28日，上市日期2018年7月13日，公司主营业务涉及专业化工供应链综合服 务商,提供以货运代理、仓储和运输为核心的一站式综合物流服务,并基于综合物流服务向化工品分销延 伸,逐步形成的化工品物贸一体化服务。主营业务收入构成为：MCD不一样的分销48.08%，MGF全球货 代业务24.02%，MWT仓配一体化17.40%，MGM全球移动9.96%，其他(补充)0.53%。 从密尔克卫十大流通股东角度 9月9日，密尔克卫跌5.08%，截至发稿，报66.39元/股，成交1.91亿元，换手率1.78%，总市值104.98亿 元。 截至发稿，周蔚文累计任职时间18年304天，现任基金资产总规模293.8亿元，任职期间最佳基金回报 504.79%， 任职期间最差基金回报-45.31%。 罗佳明累计任职时间6年72天，现任基金资产总规模132.71亿元，任职期间最佳基金回报60.1%， 任职 期间最差基金回报-26.67%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的 ...

证券日报网讯 9月8日晚间，密尔克卫发布公告称，近日，公司全资子公司上海密尔克卫化工物流有限 公司（简称"密尔克卫化工物流"）收到中海壳牌石油化工有限公司出具的《成交通知书》，在参加中海 壳牌石油化工有限公司的采购响应中，经评审小组审定，确定密尔克卫化工物流为"标的11苯乙烯SM公 路运输东莞区域200公里以内""标的12中的MTBE公路运输""标的2粤东区域道路运输+样品运输""标的8 集装罐海运、公路运输+江阴罐区的散装液体PPG产品道路运输""标的13辛醇公路运输""标的14乙二醇/ 二乙二醇公路运输"和"标的15PPG广东省外公路运输"的成交方。 （编辑 任世碧） ...

| 证券代码：603713 | 证券简称：密尔克卫 | 公告编号：2025-081 | | --- | --- | --- | | 转债代码：113658 | 转债简称：密卫转债 | | 合同金额：约人民币 1.80 亿元，具体金额将根据实际情况确定。 二、对上市公司的影响 该项目成交预计会对公司未来经营业绩产生积极影响。密尔克卫化工物流此 次成为中海壳牌石油化工有限公司 2025+公路运输及多式联运物流服务提供商， 标志着公司作为专业化工供应链服务提供商的运输交付能力得到了认可，进一步 巩固和提升了公司的影响力，对今后公司的业务发展及市场拓展产生了积极作用。 密尔克卫智能供应链服务集团股份有限公司 关于全资子公司收到成交通知书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 近日，密尔克卫智能供应链服务集团股份有限公司（以下简称"公司"）全 资子公司上海密尔克卫化工物流有限公司（以下简称"密尔克卫化工物流"）收 到中海壳牌石油化工有限公司出具的《成交通知书》，在参加中海壳牌石油化工 有限公司的采购响应中，经评审小组审定 ...